Zobrazeno 1 - 10
of 10
pro vyhledávání: '"David R Jayne"'
Autor:
Simon Bond, Rachel B Jones, Rona M Smith, Kim Mynard, David R Jayne, Matthew Coates, Dominic Paul McGovern, Mark E McClure, Marcos Martinez Del Pero, Jacinta Lee, Menna Ruth Clatworthy
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction Relapses in ANCA-associated vasculitis (AAV) increase the incidence of end-organ damage and their prevention requires prolonged immunosuppressive therapy. Rituximab, a type I anti-CD20 B cell depleting monoclonal antibody, is the current
Externí odkaz:
https://doaj.org/article/439a1bae31204d01b880ed3f725a3132
Autor:
David R Jayne, Jürgen Steffgen, Juanita Romero‐Diaz, Ingeborg Bajema, Dimitrios T Boumpas, Kajohnsak Noppakun, Hirofumi Amano, Harold Michael Gomez, Bancha Satirapoj, Yingyos Avihingsanon, Ratana Chawanasuntorapoj, Magdalena Madero, Beata Naumnik, Rhona Recto, Nora Fagan, Ivette Revollo, Jing Wu, Sudha Visvanathan, Richard Furie
Publikováno v:
Arthritis & Rheumatology.
Autor:
Andrej Ćorović, Christopher Wall, Meritxell Nus, Deepa Gopalan, Yuan Huang, Maria Imaz, Michal Zulcinski, Marta Peverelli, Anna Uryga, Jordi Lambert, Dario Bressan, Robert T. Maughan, Charis Pericleous, Suraiya Dubash, Natasha Jordan, David R. Jayne, Stephen P. Hoole, Patrick A. Calvert, Andrew F. Dean, Doris Rassl, Tara Barwick, Mark Iles, Mattia Frontini, Greg Hannon, Roido Manavaki, Tim D. Fryer, Luigi Aloj, Martin J. Graves, Fiona J. Gilbert, Marc R. Dweck, David E. Newby, Zahi A. Fayad, Gary Reynolds, Ann W. Morgan, Eric O. Aboagye, Anthony P. Davenport, Helle F. Jørgensen, Ziad Mallat, Martin R. Bennett, James E. Peters, James H.F. Rudd, Justin C. Mason, Jason M. Tarkin
Publikováno v:
Ćorović, A, Wall, C, Nus, M, Gopalan, D, Huang, Y, Imaz, M, Zulcinski, M, Peverelli, M, Uryga, A, Lambert, J, Bressan, D, Maughan, R T, Pericleous, C, Dubash, S, Jordan, N, Jayne, D R, Hoole, S P, Calvert, P A, Dean, A F, Rassl, D, Barwick, T, Iles, M, Frontini, M, Hannon, G, Manavaki, R, Fryer, T D, Aloj, L, Graves, M J, Gilbert, F J, Dweck, M R, Newby, D E, Fayad, Z A, Reynolds, G, Morgan, A W, Aboagye, E O, Davenport, A P, Jørgensen, H F, Mallat, Z, Bennett, M R, Peters, J E, Rudd, J H F, Mason, J C & Tarkin, J M 2023, ' Somatostatin Receptor PET/MR Imaging of Inflammation in Patients with Large Vessel Vasculitis and Atherosclerosis ', Journal of the American College of Cardiology, vol. 81, no. 4, pp. 336-354 . https://doi.org/10.1016/j.jacc.2022.10.034, https://doi.org/10.1016/j.jacc.2022.10.034
Background:Assessing inflammatory disease activity in large vessel vasculitis (LVV) can be challenging by conventional measures. Objectives:We aimed to investigate somatostatin receptor 2 (SST2) as a novel inflammation-specific molecular imaging targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160dc50b6bb26e3f1bcc28ffe5e6ba6c
https://zenodo.org/record/7912981
https://zenodo.org/record/7912981
Autor:
A Richard, Kitching, Hans-Joachim, Anders, Neil, Basu, Elisabeth, Brouwer, Jennifer, Gordon, David R, Jayne, Joyce, Kullman, Paul A, Lyons, Peter A, Merkel, Caroline O S, Savage, Ulrich, Specks, Renate, Kain
Publikováno v:
Nature reviews. Disease primers. 6(1)
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of disorders involving severe, systemic, small-vessel vasculitis and are characterized by the development of autoantibodies to the neutrophil proteins leukocyt
Autor:
Maria Fernandez Nieto, David R. Jayne
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 31(10)
Autor:
Maria, Fernandez Nieto, David R, Jayne
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 31(10)
Lupus nephritis (LN) therapy has limited efficacy due to its toxicity, and LN patients suffer high risks of renal and cardiovascular morbidity and mortality. Calcineurin inhibitors (CNIs) have been used for over30 years in LN treatment and are an est
Background: Plasma exchange is used in the treatment of diseases mediated by pathogenic circulating proteins, or for transplant desensitization. Its non-targeted nature results in the depletion of physiologically important molecules, and it is often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4b54972951fac511e3523a2262ec1a0
https://europepmc.org/articles/PMC3905633/
https://europepmc.org/articles/PMC3905633/
Autor:
Peter A, Merkel, Philip, Seo, Peter, Aries, Tuhina, Neogi, Alexandra, Villa-Forte, Maarten, Boers, David, Cuthbertson, David T, Felson, Bernhard, Hellmich, Gary S, Hoffman, David R, Jayne, Cees G M, Kallenberg, Jeffrey, Krischer, Alfred, Mahr, Eric L, Matteson, Ulrich, Specks, Raashid, Luqmani, John, Stone
Publikováno v:
The Journal of rheumatology. 32(12)
The complexity of assessing disease activity, disease status, and damage in the vasculitides reflects the multisystemic pathologic manifestations of these often chronic illnesses. Major progress has been made in the past decade in the development of
Publikováno v:
Nephrology Dialysis Transplantation; Aug2004, Vol. 19 Issue 8, p1964-1968, 5p
Autor:
Mark E. McClure, Seerapani Gopaluni, James Wason, Robert B. Henderson, Andre Van Maurik, Caroline C.O. Savage, Charles D. Pusey, Alan D. Salama, Paul A. Lyons, Jacinta Lee, Kim Mynard, David R. Jayne, Rachel B. Jones, on behalf the COMBIVAS investigators
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Sequential B cell-targeted immunotherapy with BAFF antagonism (belimumab) and B cell depletion (rituximab) may enhance B cell targeting in ANCA-associated vasculitis (AAV) through several mechanisms. Methods Study design: COMBIVAS
Externí odkaz:
https://doaj.org/article/de0d5603a4e24992b66dd2efe0d957ae